Kristine Kuhn is a Rheumatology/Immunology physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 136 publications with 6,575 citations (h-index 31).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1635 Aurora Ct
Aurora, CO 800452541
Telephone
720-848-7700Provider last certified this registry record 20 Apr 2026.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20259 payments
- PFIZER INC.Program year20251 payment
- UCB SAProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
76%JAK inhibitor33.3%Rinvoq70%Xeljanz30%Part D<11 patientsFolate Analog Metabolic Inhibitor20.9%Methotrexate100%Part D<11 patients+ 2 more classes in this area
Nervous system
13.2%Gabapentinoids13.2%Pregabalin100%Part D<11 patientsMetabolism & gastrointestinal
10.9%Corticosteroid10.9%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
- Microbial Drivers and Pathogenic Mechanisms in Rheumatoid Arthritis Natural History
University of Colorado Denver
FY2026$2,322,266P01AI194959 - Influence of bacterial tryptophan metabolism on inflammatory arthritis
University of Colorado Denver
FY2026$446,482R01AR075033
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Progression to rheumatoid arthritis in at-risk individuals is defined by systemic inflammation and by T and B cell dysregulation
Science Translational Medicine
2025 - Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis
Nature Reviews Rheumatology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Richard Schulick, MD, MBA
University of Colorado Anschutz Medical Campus
John Rumsfeld, MD, PhD
University of Colorado Anschutz Medical Campus
Robert Eckel, MD
University of Colorado Anschutz Medical Campus
Marc Bonaca, MD
University of Colorado Anschutz Medical Campus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”